20/20 Biolabs, Inc. Common Stock (AIDX) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.47 (-1.93%), Market cap $0.01B, 52-week low–high $1.37 ~ $23.85.
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Financial statements, price targets, institutional (13F) holdings and related news for 20/20 Biolabs, Inc. Common Stock are updated in real time on BlackAll Trade.
20/20 Biolabs, Inc. Common Stock trades at $0.47 (-1.93%). Real-time quotes and charts are available on BlackAll Trade.
20/20 Biolabs, Inc. Common Stock has a market cap of about $0.01B.
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi